Pediatric Antibiotics
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Enterobacteriaceae Infection Drug Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Beta-lactams Drugs 1.2.3 Carbapenems Drugs 1.2.4 Fluoroquinolones Drugs 1.2.5 Others 1.3 Market by Application 1.3.1 Global Enterobacteriaceae Infection Drug Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospital Pharmacies 1.3.3 Retail Pharmacies 1.3.4 Online Pharmacies 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Enterobacteriaceae Infection Drug Market Perspective (2017-2028) 2.2 Enterobacteriaceae Infection Drug Growth Trends by Region 2.2.1 Enterobacteriaceae Infection Drug Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Enterobacteriaceae Infection Drug Historic Market Size by Region (2017-2022) 2.2.3 Enterobacteriaceae Infection Drug Forecasted Market Size by Region (2023-2028) 2.3 Enterobacteriaceae Infection Drug Market Dynamics 2.3.1 Enterobacteriaceae Infection Drug Industry Trends 2.3.2 Enterobacteriaceae Infection Drug Market Drivers 2.3.3 Enterobacteriaceae Infection Drug Market Challenges 2.3.4 Enterobacteriaceae Infection Drug Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Enterobacteriaceae Infection Drug Players by Revenue 3.1.1 Global Top Enterobacteriaceae Infection Drug Players by Revenue (2017-2022) 3.1.2 Global Enterobacteriaceae Infection Drug Revenue Market Share by Players (2017-2022) 3.2 Global Enterobacteriaceae Infection Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Enterobacteriaceae Infection Drug Revenue 3.4 Global Enterobacteriaceae Infection Drug Market Concentration Ratio 3.4.1 Global Enterobacteriaceae Infection Drug Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Enterobacteriaceae Infection Drug Revenue in 2021 3.5 Enterobacteriaceae Infection Drug Key Players Head office and Area Served 3.6 Key Players Enterobacteriaceae Infection Drug Product Solution and Service 3.7 Date of Enter into Enterobacteriaceae Infection Drug Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Enterobacteriaceae Infection Drug Breakdown Data by Type 4.1 Global Enterobacteriaceae Infection Drug Historic Market Size by Type (2017-2022) 4.2 Global Enterobacteriaceae Infection Drug Forecasted Market Size by Type (2023-2028) 5 Enterobacteriaceae Infection Drug Breakdown Data by Application 5.1 Global Enterobacteriaceae Infection Drug Historic Market Size by Application (2017-2022) 5.2 Global Enterobacteriaceae Infection Drug Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Enterobacteriaceae Infection Drug Market Size (2017-2028) 6.2 North America Enterobacteriaceae Infection Drug Market Size by Country (2017-2022) 6.3 North America Enterobacteriaceae Infection Drug Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Enterobacteriaceae Infection Drug Market Size (2017-2028) 7.2 Europe Enterobacteriaceae Infection Drug Market Size by Country (2017-2022) 7.3 Europe Enterobacteriaceae Infection Drug Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Enterobacteriaceae Infection Drug Market Size (2017-2028) 8.2 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Country (2017-2022) 8.3 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Enterobacteriaceae Infection Drug Market Size (2017-2028) 9.2 Latin America Enterobacteriaceae Infection Drug Market Size by Country (2017-2022) 9.3 Latin America Enterobacteriaceae Infection Drug Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Enterobacteriaceae Infection Drug Market Size (2017-2028) 10.2 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Country (2017-2022) 10.3 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Genentech 11.1.1 Genentech Company Detail 11.1.2 Genentech Business Overview 11.1.3 Genentech Enterobacteriaceae Infection Drug Introduction 11.1.4 Genentech Revenue in Enterobacteriaceae Infection Drug Business (2017-2022) 11.1.5 Genentech Recent Development 11.2 Nanotherapeutics 11.2.1 Nanotherapeutics Company Detail 11.2.2 Nanotherapeutics Business Overview 11.2.3 Nanotherapeutics Enterobacteriaceae Infection Drug Introduction 11.2.4 Nanotherapeutics Revenue in Enterobacteriaceae Infection Drug Business (2017-2022) 11.2.5 Nanotherapeutics Recent Development 11.3 Novartis 11.3.1 Novartis Company Detail 11.3.2 Novartis Business Overview 11.3.3 Novartis Enterobacteriaceae Infection Drug Introduction 11.3.4 Novartis Revenue in Enterobacteriaceae Infection Drug Business (2017-2022) 11.3.5 Novartis Recent Development 11.4 Pfizer 11.4.1 Pfizer Company Detail 11.4.2 Pfizer Business Overview 11.4.3 Pfizer Enterobacteriaceae Infection Drug Introduction 11.4.4 Pfizer Revenue in Enterobacteriaceae Infection Drug Business (2017-2022) 11.4.5 Pfizer Recent Development 11.5 Nymox Pharmaceutical 11.5.1 Nymox Pharmaceutical Company Detail 11.5.2 Nymox Pharmaceutical Business Overview 11.5.3 Nymox Pharmaceutical Enterobacteriaceae Infection Drug Introduction 11.5.4 Nymox Pharmaceutical Revenue in Enterobacteriaceae Infection Drug Business (2017-2022) 11.5.5 Nymox Pharmaceutical Recent Development 11.6 Sequoia Sciences 11.6.1 Sequoia Sciences Company Detail 11.6.2 Sequoia Sciences Business Overview 11.6.3 Sequoia Sciences Enterobacteriaceae Infection Drug Introduction 11.6.4 Sequoia Sciences Revenue in Enterobacteriaceae Infection Drug Business (2017-2022) 11.6.5 Sequoia Sciences Recent Development 11.7 Phico Therapeutics 11.7.1 Phico Therapeutics Company Detail 11.7.2 Phico Therapeutics Business Overview 11.7.3 Phico Therapeutics Enterobacteriaceae Infection Drug Introduction 11.7.4 Phico Therapeutics Revenue in Enterobacteriaceae Infection Drug Business (2017-2022) 11.7.5 Phico Therapeutics Recent Development 11.8 Cantab Biopharmaceuticals 11.8.1 Cantab Biopharmaceuticals Company Detail 11.8.2 Cantab Biopharmaceuticals Business Overview 11.8.3 Cantab Biopharmaceuticals Enterobacteriaceae Infection Drug Introduction 11.8.4 Cantab Biopharmaceuticals Revenue in Enterobacteriaceae Infection Drug Business (2017-2022) 11.8.5 Cantab Biopharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Enterobacteriaceae Infection Drug Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Beta-lactams Drugs Table 3. Key Players of Carbapenems Drugs Table 4. Key Players of Fluoroquinolones Drugs Table 5. Key Players of Others Table 6. Global Enterobacteriaceae Infection Drug Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Enterobacteriaceae Infection Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Enterobacteriaceae Infection Drug Market Size by Region (2017-2022) & (US$ Million) Table 9. Global Enterobacteriaceae Infection Drug Market Share by Region (2017-2022) Table 10. Global Enterobacteriaceae Infection Drug Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 11. Global Enterobacteriaceae Infection Drug Market Share by Region (2023-2028) Table 12. Enterobacteriaceae Infection Drug Market Trends Table 13. Enterobacteriaceae Infection Drug Market Drivers Table 14. Enterobacteriaceae Infection Drug Market Challenges Table 15. Enterobacteriaceae Infection Drug Market Restraints Table 16. Global Enterobacteriaceae Infection Drug Revenue by Players (2017-2022) & (US$ Million) Table 17. Global Enterobacteriaceae Infection Drug Market Share by Players (2017-2022) Table 18. Global Top Enterobacteriaceae Infection Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enterobacteriaceae Infection Drug as of 2021) Table 19. Ranking of Global Top Enterobacteriaceae Infection Drug Companies by Revenue (US$ Million) in 2021 Table 20. Global 5 Largest Players Market Share by Enterobacteriaceae Infection Drug Revenue (CR5 and HHI) & (2017-2022) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Enterobacteriaceae Infection Drug Product Solution and Service Table 23. Date of Enter into Enterobacteriaceae Infection Drug Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Enterobacteriaceae Infection Drug Market Size by Type (2017-2022) & (US$ Million) Table 26. Global Enterobacteriaceae Infection Drug Revenue Market Share by Type (2017-2022) Table 27. Global Enterobacteriaceae Infection Drug Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 28. Global Enterobacteriaceae Infection Drug Revenue Market Share by Type (2023-2028) Table 29. Global Enterobacteriaceae Infection Drug Market Size by Application (2017-2022) & (US$ Million) Table 30. Global Enterobacteriaceae Infection Drug Revenue Market Share by Application (2017-2022) Table 31. Global Enterobacteriaceae Infection Drug Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 32. Global Enterobacteriaceae Infection Drug Revenue Market Share by Application (2023-2028) Table 33. North America Enterobacteriaceae Infection Drug Market Size by Country (2017-2022) & (US$ Million) Table 34. North America Enterobacteriaceae Infection Drug Market Size by Country (2023-2028) & (US$ Million) Table 35. Europe Enterobacteriaceae Infection Drug Market Size by Country (2017-2022) & (US$ Million) Table 36. Europe Enterobacteriaceae Infection Drug Market Size by Country (2023-2028) & (US$ Million) Table 37. Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Region (2017-2022) & (US$ Million) Table 38. Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Region (2023-2028) & (US$ Million) Table 39. Latin America Enterobacteriaceae Infection Drug Market Size by Country (2017-2022) & (US$ Million) Table 40. Latin America Enterobacteriaceae Infection Drug Market Size by Country (2023-2028) & (US$ Million) Table 41. Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Country (2017-2022) & (US$ Million) Table 42. Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Country (2023-2028) & (US$ Million) Table 43. Genentech Company Detail Table 44. Genentech Business Overview Table 45. Genentech Enterobacteriaceae Infection Drug Product Table 46. Genentech Revenue in Enterobacteriaceae Infection Drug Business (2017-2022) & (US$ Million) Table 47. Genentech Recent Development Table 48. Nanotherapeutics Company Detail Table 49. Nanotherapeutics Business Overview Table 50. Nanotherapeutics Enterobacteriaceae Infection Drug Product Table 51. Nanotherapeutics Revenue in Enterobacteriaceae Infection Drug Business (2017-2022) & (US$ Million) Table 52. Nanotherapeutics Recent Development Table 53. Novartis Company Detail Table 54. Novartis Business Overview Table 55. Novartis Enterobacteriaceae Infection Drug Product Table 56. Novartis Revenue in Enterobacteriaceae Infection Drug Business (2017-2022) & (US$ Million) Table 57. Novartis Recent Development Table 58. Pfizer Company Detail Table 59. Pfizer Business Overview Table 60. Pfizer Enterobacteriaceae Infection Drug Product Table 61. Pfizer Revenue in Enterobacteriaceae Infection Drug Business (2017-2022) & (US$ Million) Table 62. Pfizer Recent Development Table 63. Nymox Pharmaceutical Company Detail Table 64. Nymox Pharmaceutical Business Overview Table 65. Nymox Pharmaceutical Enterobacteriaceae Infection Drug Product Table 66. Nymox Pharmaceutical Revenue in Enterobacteriaceae Infection Drug Business (2017-2022) & (US$ Million) Table 67. Nymox Pharmaceutical Recent Development Table 68. Sequoia Sciences Company Detail Table 69. Sequoia Sciences Business Overview Table 70. Sequoia Sciences Enterobacteriaceae Infection Drug Product Table 71. Sequoia Sciences Revenue in Enterobacteriaceae Infection Drug Business (2017-2022) & (US$ Million) Table 72. Sequoia Sciences Recent Development Table 73. Phico Therapeutics Company Detail Table 74. Phico Therapeutics Business Overview Table 75. Phico Therapeutics Enterobacteriaceae Infection Drug Product Table 76. Phico Therapeutics Revenue in Enterobacteriaceae Infection Drug Business (2017-2022) & (US$ Million) Table 77. Phico Therapeutics Recent Development Table 78. Cantab Biopharmaceuticals Company Detail Table 79. Cantab Biopharmaceuticals Business Overview Table 80. Cantab Biopharmaceuticals Enterobacteriaceae Infection Drug Product Table 81. Cantab Biopharmaceuticals Revenue in Enterobacteriaceae Infection Drug Business (2017-2022) & (US$ Million) Table 82. Cantab Biopharmaceuticals Recent Development Table 83. Research Programs/Design for This Report Table 84. Key Data Information from Secondary Sources Table 85. Key Data Information from Primary Sources List of Figures Figure 1. Global Enterobacteriaceae Infection Drug Market Share by Type: 2021 VS 2028 Figure 2. Beta-lactams Drugs Features Figure 3. Carbapenems Drugs Features Figure 4. Fluoroquinolones Drugs Features Figure 5. Others Features Figure 6. Global Enterobacteriaceae Infection Drug Market Share by Application in 2021 & 2028 Figure 7. Hospital Pharmacies Case Studies Figure 8. Retail Pharmacies Case Studies Figure 9. Online Pharmacies Case Studies Figure 10. Enterobacteriaceae Infection Drug Report Years Considered Figure 11. Global Enterobacteriaceae Infection Drug Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 12. Global Enterobacteriaceae Infection Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Enterobacteriaceae Infection Drug Market Share by Region: 2021 VS 2028 Figure 14. Global Enterobacteriaceae Infection Drug Market Share by Players in 2021 Figure 15. Global Top Enterobacteriaceae Infection Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enterobacteriaceae Infection Drug as of 2021) Figure 16. The Top 10 and 5 Players Market Share by Enterobacteriaceae Infection Drug Revenue in 2021 Figure 17. North America Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. North America Enterobacteriaceae Infection Drug Market Share by Country (2017-2028) Figure 19. United States Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Canada Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Enterobacteriaceae Infection Drug Market Share by Country (2017-2028) Figure 23. Germany Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. France Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. U.K. Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Italy Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Russia Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Nordic Countries Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Enterobacteriaceae Infection Drug Market Share by Region (2017-2028) Figure 31. China Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Japan Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. South Korea Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Southeast Asia Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. India Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Australia Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Latin America Enterobacteriaceae Infection Drug Market Share by Country (2017-2028) Figure 39. Mexico Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Brazil Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Middle East & Africa Enterobacteriaceae Infection Drug Market Share by Country (2017-2028) Figure 43. Turkey Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Saudi Arabia Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Genentech Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2017-2022) Figure 46. Nanotherapeutics Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2017-2022) Figure 47. Novartis Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2017-2022) Figure 48. Pfizer Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2017-2022) Figure 49. Nymox Pharmaceutical Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2017-2022) Figure 50. Sequoia Sciences Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2017-2022) Figure 51. Phico Therapeutics Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2017-2022) Figure 52. Cantab Biopharmaceuticals Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2017-2022) Figure 53. Bottom-up and Top-down Approaches for This Report Figure 54. Data Triangulation Figure 55. Key Executives Interviewed
Genentech Nanotherapeutics Novartis Pfizer Nymox Pharmaceutical Sequoia Sciences Phico Therapeutics Cantab Biopharmaceuticals
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Transplantation Therapeutics Drugs market is segmented by players, region (country), by Type and ... Read More
Pediatric Healthcare Service market is segmented by players, region (country), by Type and by App ... Read More
Elbow Replacement market is segmented by players, region (country), by Type and by Application. P ... Read More